Raffaella Gozzelino
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Cell Death Regulation and Role in Infection and Inflammatory Diseases
Open Date: 2022-01-01
Close Date: 2025-12-31
Grant: Close
Stress-induced neuroinflammation: mechanisms and implications for decision-making and performance
Open Date: 2018-12-02
Close Date: 2021-12-01
Grant: Close
MOlecular mechanisms of cellular DEath and Life decisions in Inflammation, Degeneration and Infection
Open Date: 2018-01-01
Close Date: 2022-01-01
Grant: Close
NEw Targets in DIAstolic heart failure: from coMOrbidities to persoNalizeD medicine (NETDIAMOND)
Open Date: 2017-01-01
Close Date: 2020-01-01
Grant: Close
Immunity and Inflammation in Parkinson's disease
Open Date: 2016-09-15
Close Date: 2021-08-14
Articles (4)
Parkinson’s disease (PD) is a multifactorial neurodegenerative pathology characterized by the progressive loss of dopaminergic neurons in the substantia nigra of the brain. Aging is considered the main risk factor for the development of idiopathic PD. However, immunity and inflammation play a crucial role in the pathogenesis of this disorder. In mice, we showed that pro-inflammatory priming of the brain sensitizes to severe PD development, regardless of animal age. Age-related sub-acute inflammation, as well as the activation of the immune response upon exposure to harmful stimuli, enhances PD manifestations. The severity of PD is influenced by the engagement of host resistance mechanisms against infection based on the removal of iron (Fe) from the circulation. The sequestration of Fe by immune cells prevents pathogens from proliferating. However, it leads to the formation of a Fe-loaded circulating compartment. When entering the brain through a compromised blood-brain barrier, Fe-loaded immune cells contribute to enhancing neuroinflammation and brain Fe overload. Thus, pro-inflammatory priming of the brain exacerbates neuronal damage and represents a risk factor for the development of severe PD symptoms. Further investigations are now required to better understand whether therapeutic interventions inhibiting this phenomenon might protect against PD.
Year:
2023
Year:
2023
Year:
2022
Year:
2021
Collaborators (4)
Sérgio F de Almeida
Universidade do Porto Faculdade de Medicina
Jacques Neefjes
Professor, head department
Leiden University Medical Center
Luis Moita
Associate Professor
Universidade Autónoma de Lisboa
Ana Messias
Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit
Make your next move.
Prepare your application
Review drafts before you send them.